ResearchPHAT
PHAT: FY25 Deep Dive
Published 1 min read
Phathom Pharmaceuticals FY25 at $175M. NI $-221M; EPS $-3.03.
PHAT: FY25 Deep Dive
FY25 revenue $175M; OI $-160M; NI $-221M; EPS $-3.03.
Phathom Pharmaceuticals FY25 (Dec 31, 2025) at $175M revenue. OpInc $-160M; NI $-221M; EPS $-3.03. Pharma — GI.
